Cybin Inc. HELP

Updated: 10 Aug 2026

NASDAQ | Biotech | Biotechnology / Psychedelic therapeutics

No signal published yet

We already track Cybin and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Cybin free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology / Psychedelic therapeutics
We're already tracking Cybin Inc. — here are the latest events we've registered

Recent News

  • On August 3, 2026, the company announced the appointment of Michael Halstead as Chief Executive Officer. The leadership transition comes ahead of anticipated top-line Phase 3 clinical trial results for its lead candidate HLP003 in major depressive disorder expected in late 2026.

What Firelda Watch includes for Cybin Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Cybin Inc. will be delivered in the same format.

Want to follow Cybin Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Cybin free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Cybin Inc. HELP
Cybin — follow and we'll monitor it
Follow Cybin free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.